Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Neprilysin, corin singled out for potential to guide heart failure therapy

    January 28, 2021

    Circulating neprilysin and corin concentrations, which correlate with outcomes, could possibly be assessed to guide heart failure therapy.

  • 1
    News

    Myocarditis by CMR may be rare after COVID-19 in elite athletes

    January 27, 2021

    Some supposed ‘myocarditis’ detected by MRI after COVID-19 in university varsity competitors might be normal heart muscle – normal for athletes, that is, propose researchers.

  • News

    Full-dose anticoagulation reduces need for life support in COVID-19

    January 25, 2021

    “We have treatments that are improving outcomes but not as many that reduce mortality, so we’re hopeful when the full dataset comes in that will be confirmed.”

  • 1
    News

    Think twice before intensifying BP regimen in older hospitalized patients

    January 20, 2021

    Does intensifying antihypertensive regimens in older patients hospitalized for noncardiac conditions lead to better long-term blood pressure control or does this practice potentially cause harm?

  • News

    Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes

    January 19, 2021

    Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying best candidates for SGLT2 inhibitor therapy, some say.

  • 1
    News

    CVD deaths rose, imaging declined during pandemic

    January 14, 2021

    Two new papers quantify the impact of COVID-19 on patients with heart disease: more deaths, less disease testing or diagnosis. Experts suggest shutdowns may have been too complete.

  • 1
    News

    A standardized approach to postop management of DOACs in AFib

    January 13, 2021

    Is it safe to adopt a standardized approach to direct oral anticoagulant (DOAC) interruption for patients with atrial fibrillation (AFib) who are undergoing elective surgeries/procedures?

  • 1
    News

    Calcium-induced autonomic denervation linked to lower post-op AF

    January 13, 2021

    Although targeting the four major atrial ganglionated plexi reduced post-CABG atrial fibrillation, it’s not clear whether it can prevent stroke.

  • News

    In COVID-19 patients, risk of bleeding rivals risk of thromboembolism

    January 12, 2021

    Trials are urgently needed to define optimal anticoagulation strategies for COVID-19 infection.

  • 1
    News

    Updated ACC decision pathway embraces new heart failure treatment strategies

    January 11, 2021

    The ACC’s updated decision pathway aims to close the substantial gap between current practice and unmet opportunities for inhibiting HFrEF progression.

Previous1 … 19 20 21 22 23 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences